ABSI
Price
$8.93
Change
+$0.13 (+1.48%)
Updated
Sep 4, 12:22 PM (EDT)
Capitalization
1.51B
74 days until earnings call
Intraday BUY SELL Signals
PRME
Price
$3.69
Change
-$0.02 (-0.54%)
Updated
Sep 4, 01:24 PM (EDT)
Capitalization
671.09M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs PRME

ABSI vs PRME Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABSI vs. PRME commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and PRME is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2026
Stock price -- (ABSI: $8.80 vs. PRME: $3.71)
Brand notoriety: ABSI and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 99% vs. PRME: 76%
Market capitalization -- ABSI: $1.51B vs. PRME: $671.09M
ABSI [@Biotechnology] is valued at $1.51B. PRME’s [@Biotechnology] market capitalization is $671.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $141.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 1 green, 4 red.
According to our system of comparison, PRME is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 6 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 5 bearish.
  • PRME’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PRME is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -6.58% price change this week, while PRME (@Biotechnology) price change was +1.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +2396.61%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 17, 2026.

PRME is expected to report earnings on Oct 30, 2026.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($1.51B) has a higher market cap than PRME($671M). ABSI YTD gains are higher at: 152.149 vs. PRME (6.916). ABSI has higher annual earnings (EBITDA): -106.8M vs. PRME (-199.14M). PRME has more cash in the bank: 135M vs. ABSI (126M). ABSI has less debt than PRME: ABSI (4.42M) vs PRME (115M). PRME has higher revenues than ABSI: PRME (4.03M) vs ABSI (1.84M).
ABSIPRMEABSI / PRME
Capitalization1.51B671M225%
EBITDA-106.8M-199.14M54%
Gain YTD152.1496.9162,200%
P/E RatioN/AN/A-
Revenue1.84M4.03M46%
Total Cash126M135M93%
Total Debt4.42M115M4%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIPRME
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 24 days ago
90%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signal:
Gain/Loss:
PRME
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SUSL138.531.83
+1.34%
iShares ESG MSCI USA Leaders ETF
GMOI42.060.43
+1.03%
GMO International Value ETF
FPRO24.850.22
+0.90%
Fidelity Real Estate Investment ETF
GMOM38.640.18
+0.47%
Cambria Global Momentum ETF
QID14.20-0.34
-2.34%
ProShares UltraShort QQQ